Aortic and Vascular Graft Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Aortic and Vascular Graft Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Aortic and Vascular Graft Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Aortic and Vascular Graft Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Aortic Stent grafts are used to reinforce a weaken aorta to prevent ruptures. Vascular grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Aortic and Vascular Graft Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Aortic and Vascular Graft Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Aortic and Vascular Graft Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Aortic and Vascular Graft Devices Overview
4 Products under Development
4.1 Aortic and Vascular Graft Devices - Pipeline Products by Stage of Development
4.2 Aortic and Vascular Graft Devices - Pipeline Products by Territory
4.3 Aortic and Vascular Graft Devices - Pipeline Products by Regulatory Path
4.4 Aortic and Vascular Graft Devices - Pipeline Products by Estimated Approval Date
4.5 Aortic and Vascular Graft Devices - Ongoing Clinical Trials
5 Aortic and Vascular Graft Devices - Pipeline Products under Development by Companies
5.1 Aortic and Vascular Graft Devices Companies - Pipeline Products by Stage of Development
5.2 Aortic and Vascular Graft Devices – Companies Pipeline Products by Stage of Development
6 Aortic and Vascular Graft Devices Companies and Product Overview
6.1 Acro Biomedical Co Ltd Company Overview
6.1.1 Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.2 BioLife4D Corp Company Overview
6.2.1 BioLife4D Corp Pipeline Products & Ongoing Clinical Trials Overview
6.3 Cook Medical Inc Company Overview
6.3.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.4 Drexel University Company Overview
6.4.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview
6.5 Endomimetics LLC Company Overview
6.5.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview
6.6 Endoron Medical Ltd Company Overview
6.6.1 Endoron Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.7 Humacyte Inc Company Overview
6.7.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
6.8 Innoventric Ltd Company Overview
6.8.1 Innoventric Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.9 Merit Medical Systems Inc Company Overview
6.9.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
6.1 Shanghai MicroPort Endovascular MedTech Group Co Ltd Company Overview
6.10.1 Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.11 Stanford University Company Overview
6.11.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
6.12 Strait Access Technologies (Pty) Ltd Company Overview
6.12.1 Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.13 University of Toledo Company Overview
6.13.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview
6.14 Vascular Graft Solutions Ltd Company Overview
6.14.1 Vascular Graft Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.15 Verigraft AB Company Overview
6.15.1 Verigraft AB Pipeline Products & Ongoing Clinical Trials Overview
7 Aortic and Vascular Graft Devices- Recent Developments
7.1 Apr 24, 2024: Meihua International Medical Technologies Reports 2023 Financial Year Results
7.2 Mar 29, 2024: MicroPort CardioFlow Medtech Full Year 2023 Earnings
7.3 Oct 31, 2023: Meihua International Medical Technologies, Establishes A Subsidiary Dedicated to Introducing International Patented Pharmaceuticals and Medical Device
7.4 Oct 16, 2023: Humacyte Publishes Preclinical Results Showing Human Acellular Vessel (HAV) Patency as Modified Blalock–Taussig–Thomas Shunt in Juvenile Primate Model
7.5 Oct 15, 2023: Shanghai Kindly Medical Instruments Co. Notice of 2023 First Extraordinary General Meeting
7.6 Oct 05, 2023: Shanghai Kindly Medical Instruments Co. Announces 2022 Annual Report
7.7 Oct 02, 2023: Swedish Personalized Tissue Graft Company Verigraft Reports Promising Interim Results From a First-In-Man Study in Patients With Deep Venous Insufficiency at 2023 Cell & Gene Meeting on the Mesa
7.8 Aug 29, 2023: MicroPort CardioFlow Medtech Corp. Announces Change of Directors and Chairman
7.9 Aug 29, 2023: Microport Cardioflow Medtech Announces Change of Directors and Chairman
7.1 May 18, 2023: Shanghai Kindly Medical Instruments Co. Announces Poll Results of Annual General Meeting & Payment of Final Dividend
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Aortic and Vascular Graft Devices - Pipeline Products by Stage of Development
Table 2: Aortic and Vascular Graft Devices - Pipeline Products by Territory
Table 3: Aortic and Vascular Graft Devices - Pipeline Products by Regulatory Path
Table 4: Aortic and Vascular Graft Devices - Pipeline Products by Estimated Approval Date
Table 5: Aortic and Vascular Graft Devices - Ongoing Clinical Trials
Table 6: Aortic and Vascular Graft Devices Companies - Pipeline Products by Stage of Development
Table 7: Aortic and Vascular Graft Devices – Companies Pipeline Products by Stage of Development
Table 8: Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 9: ACROARTERY - Product Status
Table 10: ACROARTERY - Product Description
Table 11: BioLife4D Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Cardiac Graft - Product Status
Table 13: Cardiac Graft - Product Description
Table 14: Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Zenith Eterna - Product Status
Table 16: Zenith Eterna - Product Description
Table 17: Drexel University Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Hydrogel-Based Chemically-Eluting Shunt Prosthesis - Product Status
Table 19: Hydrogel-Based Chemically-Eluting Shunt Prosthesis - Product Description
Table 20: Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Stent Graft - Product Status
Table 22: Stent Graft - Product Description
Table 23: Endoron Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Aortoseal - Product Status
Table 25: Aortoseal - Product Description
Table 26: Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Humacyl Graft - Pediatric Heart Surgery - Product Status
Table 28: Humacyl Graft - Pediatric Heart Surgery - Product Description
Table 29: Innoventric Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Trillium - Product Status
Table 31: Trillium - Product Description
Table 32: Innoventric Ltd - Ongoing Clinical Trials Overview
Table 33: Trillium - Early Feasibility Study (EFS) to Assess the Safety and Performance of the Innoventric Trillium Stent Graft in the Treatment of Severe or Greater Tricuspid Regurgitation (TR)
Table 34: Trillium - Prospective, Single Arm, Multi-center, First-in-human (FIH) Study to Assess the Safety and Performance of the Innoventric Trillium Stent Graft for the Treatment of Severe Tricuspid Regurgitation (TR)
Table 35: Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 36: WRAPSODY Endovascular Stent Graft - Venous Occlusive Disease - Product Status
Table 37: WRAPSODY Endovascular Stent Graft - Venous Occlusive Disease - Product Description
Table 38: Merit Medical Systems Inc - Ongoing Clinical Trials Overview
Table 39: WRAPSODY Endovascular Stent Graft - Venous Occlusive Disease - Prospective, Randomized, Controlled, Multicenter Study Comparing the Merit WRAPSODY Endovascular Stent Graft to Percutaneous Transluminal Angioplasty for Treatment of Venous Outflow Circuit Stenosis or Occlusion in Hemodialysis Patients: The WAVE Study
Table 40: Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Aortic Vascular Intervention Device - Product Status
Table 42: Aortic Vascular Intervention Device - Product Description
Table 43: Stanford University Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Geometric Aortic Graft - Product Status
Table 45: Geometric Aortic Graft - Product Description
Table 46: Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 47: TEVAR/EVAR Molding Balloon - Product Status
Table 48: TEVAR/EVAR Molding Balloon - Product Description
Table 49: University of Toledo Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Aortic Endograft Fenestration Device - Product Status
Table 51: Aortic Endograft Fenestration Device - Product Description
Table 52: Vascular Graft Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 53: VEST - Product Status
Table 54: VEST - Product Description
Table 55: Vascular Graft Solutions Ltd - Ongoing Clinical Trials Overview
Table 56: VEST - A Multi-center, Randomized, Within-subject-controlled, Open Label Study of the Safety and Effectiveness of VEST, Venous External Support
Table 57: Verigraft AB Pipeline Products & Ongoing Clinical Trials Overview
Table 58: P-TEV - Product Status
Table 59: P-TEV - Product Description
Table 60: Verigraft AB - Ongoing Clinical Trials Overview
Table 61: P-TEV - Phase I Open-label, First-in-human Study to Evaluate Feasibility and Safety of Tissue Engineered Veins in Patients With Chronic Venous Insufficiency
Table 62: Glossary
2.2. List of Figures
Figure 1: Aortic and Vascular Graft Devices - Pipeline Products by Stage of Development
Figure 2: Aortic and Vascular Graft Devices - Pipeline Products by Territory
Figure 3: Aortic and Vascular Graft Devices - Pipeline Products by Regulatory Path
Figure 4: Aortic and Vascular Graft Devices - Pipeline Products by Estimated Approval Date
Figure 5: Aortic and Vascular Graft Devices - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings